Geunyoung Beak
Papers
1
Total Citations
24
H-Index
1
About
Geunyoung Beak is a pioneering researcher at the intersection of biohybrid robotics, microphysiological systems, and neurodegenerative disease modeling. His work centers on developing innovative "robot-on-a-chip" platforms that integrate living human motor systems with microfluidic devices, enabling unprecedented drug evaluation for conditions like amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. Beak’s landmark 2023 study, "Human Motor System‐Based Biohybrid Robot‐On‐a‐Chip for Drug Evaluation of Neurodegenerative Disease," has already garnered 24 citations, reflecting its immediate impact. His major contribution lies in overcoming a critical limitation of prior biohybrid robots—the lack of a central nervous system—by incorporating motor organoids and neuromuscular junctions directly onto a chip. This breakthrough allows real-time monitoring of neural control over robotic actuators, creating a physiologically relevant platform for testing neuroprotective compounds. Beak’s work bridges robotics and tissue engineering, offering a transformative tool for preclinical drug screening. His achievements have positioned him as a rising leader in organ-on-a-chip technology, with his research promising to accelerate therapeutic discovery for devastating neurological disorders.
Research Focus
Key Achievements
Top Papers
- 1